[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$BMY/Orbital deal sparks positive sentiment, driving engagements and mentions. Community engagement is high, with potential for further growth.
A cryptocurrency project.
Engagements 24-Hour Time-Series Raw Data
Current Value: XX
Daily Average: XXX
1-Year High: XXX on 2025-10-12
1-Year Low: XX on 2025-10-15
Social Network | X |
---|---|
Engagements | XX |
Mentions 24-Hour Time-Series Raw Data
Current Value: X
Daily Average: X
1-Year High: X on 2025-10-12
1-Year Low: X on 2025-10-14
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Time-Series Raw Data
X unique social accounts have posts mentioning $bmyorbital in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: X
1-Year High: X on 2025-10-12
1-Year Low: X on 2025-10-14
Top assets mentioned In the posts about $bmyorbital in the last XX hours
Top topics mentioned In the posts about $bmyorbital in the last XX hours
$akro, $novo, $mplt, ipo, $beam, coins defi, coins bsc, coins dao, coins gaming, $ipsc, javascript
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Surprised $BEAM not yet up on this $1.5B $BMY/Orbital deal. BEAM owned XXXX% of Orbital at founding; this was likely diluted in the Series A but could still be substantial cash for BEAM in addition to squishier platform validation. Gene editing stocks have moved on much less"
X Link @pemulisking 2025-10-10T14:05Z XXX followers, 1759 engagements
"On todays #BiotechHangout @t_lorriman @BrianSkorney @SamFazeli8 @YaronWerber & @luba_greenwood will cover deals & financings: $AKRO/$NOVO #MASH deal $BMY/Orbital deal MapLight ($MPLT) IPO AI Pharma deals: $AZN/Algen $SNY/BenchSci Nilo Therapeutics $101M Series A Ascentas $325M first biotech fund company news: $RCUS #ccRCC data $SKYE CBeyond Phase 2a data $DYN DM1 data & #WMS2025 DMD presentations $IONS Innovation Day regulatory: $LXEO FDA update Peter Marks joins $LLY plus board evolution & effective vs. ineffective boards much more:"
X Link @BiotechCH 2025-10-10T13:35Z 15.1K followers, 5830 engagements
"@NextTradeX no one knows which modality wins. Thats why I size small and wait for proof. $IPSC may be cheap but it still needs clinical traction in autoimmune and clean mfg. Ill buy capitulation and treat $BMY/Orbital as a sector tailwind not a 1:1 read-through"
X Link @QueenBioInvest 2025-10-10T12:50Z XXX followers, XXX engagements